Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-23

Clinical Trial Update: Liraglutide in Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update for liraglutide in Type 1 Diabetes; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: University at Buffalo | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2024-01-23